Sanofi: FDA approves asthma indication for Dupixent® (dupilumab)
Go back to Sanofi: FDA approves asthma indication for Dupixent® (dupilumab)| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.19 | 52 Week High | $5.58 | |||
| Open | $14.19 | 52 Week Low | $3.60 | |||
| Day High | $14.19 | P/E | N/A | |||
| Day Low | $14.19 | EPS | $0.00 | |||
| Volume | 67,872 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 40.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.74 | 52 Week High | $44.76 | |||
| Open | $40.74 | 52 Week Low | $36.81 | |||
| Day High | $40.74 | P/E | N/A | |||
| Day Low | $40.74 | EPS | $0.00 | |||
| Volume | 127,315 | |||||
